188 related articles for article (PubMed ID: 22627991)
1. Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome.
Sandset EC; Murray GD; Bath PM; Kjeldsen SE; Berge E;
Stroke; 2012 Aug; 43(8):2108-14. PubMed ID: 22627991
[TBL] [Abstract][Full Text] [Related]
2. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.
Sandset EC; Bath PM; Boysen G; Jatuzis D; Kõrv J; Lüders S; Murray GD; Richter PS; Roine RO; Terént A; Thijs V; Berge E;
Lancet; 2011 Feb; 377(9767):741-50. PubMed ID: 21316752
[TBL] [Abstract][Full Text] [Related]
3. Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage.
Jusufovic M; Berge TE; Guo R; You S; Delcourt C; Anderson C; Bath PM; Karlson BW; Berge E; Sandset EC;
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2262-2267. PubMed ID: 31178359
[TBL] [Abstract][Full Text] [Related]
4. A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
Lee JH; Yang DH; Hwang JY; Hur SH; Cha TJ; Kim KS; Kim MH; Chun KJ; Cha GS; Hong GR; Lee SG; Kim DS; Kim DI; Chae SC
Clin Ther; 2016 Jun; 38(6):1485-1497. PubMed ID: 27161546
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke.
Jusufovic M; Sandset EC; Bath PM; Berge E;
Stroke; 2014 Nov; 45(11):3440-2. PubMed ID: 25256183
[TBL] [Abstract][Full Text] [Related]
6. Lowering blood pressure in acute stroke: the SCAST trial.
Hankey GJ
Lancet; 2011 Feb; 377(9767):696-8. PubMed ID: 21316753
[No Abstract] [Full Text] [Related]
7. Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke.
Sandset EC; Jusufovic M; Sandset PM; Bath PM; Berge E;
Stroke; 2015 Mar; 46(3):877-9. PubMed ID: 25657183
[TBL] [Abstract][Full Text] [Related]
8. Effects of candesartan in acute stroke on cognitive function and quality of life: results from the Scandinavian Candesartan Acute Stroke Trial.
Hornslien AG; Sandset EC; Bath PM; Wyller TB; Berge E;
Stroke; 2013 Jul; 44(7):2022-4. PubMed ID: 23660849
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure management in acute stroke: does the Scandinavian Candesartan Acute Stroke Trial (SCAST) resolve all of the unanswered questions?
Fischer U; Rothwell PM
Stroke; 2011 Oct; 42(10):2995-8. PubMed ID: 21852619
[No Abstract] [Full Text] [Related]
10. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
[TBL] [Abstract][Full Text] [Related]
11. Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis.
Jusufovic M; Sandset EC; Bath PM; Karlson BW; Berge E;
Int J Stroke; 2015 Apr; 10(3):354-9. PubMed ID: 25472578
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003).
Sandset EC; Murray G; Boysen G; Jatuzis D; Kõrv J; Lüders S; Richter PS; Roine RO; Terént A; Thijs V; Berge E;
Int J Stroke; 2010 Oct; 5(5):423-7. PubMed ID: 20854630
[TBL] [Abstract][Full Text] [Related]
14. Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST).
Hornslien AG; Sandset EC; Igland J; Terént A; Boysen G; Bath PM; Murray GD; Berge E
Int J Stroke; 2015 Aug; 10(6):830-5. PubMed ID: 25808741
[TBL] [Abstract][Full Text] [Related]
15. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
[TBL] [Abstract][Full Text] [Related]
16. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
Lithell H; Hansson L; Skoog I; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A;
J Hypertens; 2003 May; 21(5):875-86. PubMed ID: 12714861
[TBL] [Abstract][Full Text] [Related]
17. Early blood pressure lowering treatment in acute stroke. Ordinal analysis of vascular events in the Scandinavian Candesartan Acute Stroke Trial (SCAST).
Jusufovic M; Sandset EC; Bath PM; Berge E;
J Hypertens; 2016 Aug; 34(8):1594-8. PubMed ID: 27228435
[TBL] [Abstract][Full Text] [Related]
18. Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies.
Wei F; Jia XJ; Yu SQ; Gu Y; Wang L; Guo XM; Wang M; Zhu F; Cheng X; Wei YM; Zhou ZH; Fu M; Liao YH;
Heart; 2011 Mar; 97(6):479-84. PubMed ID: 21296780
[TBL] [Abstract][Full Text] [Related]
19. Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study.
Wang X; Arima H; Heeley E; Delcourt C; Huang Y; Wang J; Stapf C; Robinson T; Woodward M; Chalmers J; Anderson CS;
Hypertension; 2015 May; 65(5):1026-32. PubMed ID: 25801872
[TBL] [Abstract][Full Text] [Related]
20. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
